Automated testing solutions for improving healthcare in India

In India, the growth of the population, urbanization, changes in lifestyles, advancements in medical technology, and increased health awareness have led to rising public expectations for precise diagnoses and timely treatments. Therefore, providing high-quality IVD testing has become particularly important to meet patients’ needs for reliable and swift assessments.

Our goal is to offer higher-quality and more comprehensive testing in India, ensuring that every patient receives exact and prompt evaluations to address the growing healthcare needs. To achieve this, we will actively research and develop cutting-edge testing technologies and equipment and establish efficient laboratory management systems to optimize processes while enhancing both efficiency and accuracy. Additionally, we will gain an in-depth understanding of local market requirements to customize testing projects and solutions that align with the characteristics of the Indian market, ensuring that our initiatives effectively address the unique health challenges faced in the region.

Snibe’s independently developed and produced fully automated laboratory solution, SATLARSTM T8, can provide unified services and iterative technologies, avoiding supply chain disruptions caused by war or economic sanctions. SATLARSTM T8 is an excellent TLA system with the highlights of flexibility, scalability, efficiency, and intelligence, to help your laboratories achieve a fully automatic testing process. The system consists of four main components: pre-analytical module, analysis module, post-analytical module, and conveyors. The pre-analytical module includes sample input/output, centrifugation, decapping, and so on, enabling automated loading and classification of samples to enhance testing efficiency and accuracy. The analytical module comprises immunoassay, biochemical, molecular, coagulation, and electrolyte analyzers. For example, the immunoassay analyzer MAGLUMI X8 has a processing capacity of up to 600 T/H, while the biochemical analyzer Biossays C8 can process up to 1600 T/H. The molecular analyzer Molecision R8 has a capacity of 448 T/8H, and the coagulation analyzer Hemolumi H6 is also compatible with SATLARSTM T8. These analyzers can meet various needs and provide efficient testing, allowing users to free up their hands for other tasks. The post-analytical module includes sealing/unsealing functions, as well as cold storage capabilities that support the storage of various sample tubes to prevent cross-contamination. The cold storage module has a large capacity that can accommodate over 15,000 sample tubes. Regarding the conveyors system, the connecting tracks have different interfaces such as T-shaped, L-shaped, I-shaped, and U-shaped, allowing for flexible assembly based on laboratory layouts to achieve customized services.

Snibe offers a comprehensive testing menu that includes over 260 parameters, covering a wide range of diseases to adapt to the ever-changing market demands. Each year, we will also add 10 to 20 new parameters based on the latest scientific research and clinical practices to ensure our testing projects remain at the forefront of the industry. Additionally, we place significant emphasis on understanding and addressing the unique needs of the Indian market by offering targeted special reagent projects. One such initiative focuses on dengue fever, a pressing public health challenge in the region. To effectively combat this issue, Snibe provide specialized reagents for dengue detection, including quantitative measurement of dengue virus NS1 antigen (DENV NS1), anti-dengue virus IgG (DENV IgG), and qualitative measurement of anti-dengue virus IgM (DENV IgM). These reagents are designed with high performance in mind, boasting a specificity of up to 98.88 percent and a sensitivity of 96.97 percent. This level of precision is crucial for healthcare professionals, as it enables them to identify and diagnose dengue infections at an early stage, thereby facilitating timely intervention and treatment. All reagents are ready-to-use, greatly simplifying laboratory operations and improving work efficiency.

Additionally, Snibe has established a professional technical team locally in India, with team members possessing rich industry experience and technical expertise, enabling them to respond quickly to customer needs. This team provides comprehensive pre-sales, in-sales, and after-sales services, particularly excelling in after-sales support by promptly addressing various issues that users encounter during operation, ensuring the normal functioning and high performance of the equipment. Through this localized support, Snibe is committed to enhancing customer satisfaction and assisting healthcare institutions in better meeting their daily testing requirements, thereby promoting the overall quality of medical services.

We uphold the principle of “guarding product quality as we guard life”, remaining customer-centric and market-oriented. Through continuous product and technological innovation, we strive to create value for global healthcare and establish ourselves as a pioneer in the IVD industry worldwide.